longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Stablecoin Development

SDEV

1.27027.00% ( +0.270 )
Closed: Sep 22, 16:00:00 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 0.10, within the reasonable range, cheaper than 51.24% of the time in the past 1 years, and the industry ranks 2/257, the industry Median -1.38.

0.105xP/E
$1.00Stock price
$9.55Earnings per share
0.105xP/E
Stock price$1.00Earnings per share$9.55

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
0.10x
Typical range
-1.58x–0.12x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0306090120

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
NVOUSNovo Nordisk AS
9.73x6.63%$176.03B
SGIOYUSShionogi
9.53x--$16.05B
HYPMYUSHypera S.A.
9.97x--$3.27B
INVAUSInnoviva
4.26x34.79%$1.52B
APMDUSApnimed
6.38x114.94%$1.04B
CRMDUSCormedix
3.26x76.08%$605.63M
ORMPUSOramed Pharma
1.12x198.00%$195.51M
OGIUSOrganigram
2.43x510.33%$151.21M
SDEVUSStablecoin Development
0.10x--$50.62M
BTMDUSbiote Corp.
8.13x127.70%$47.60M
OWPCUSOne World Products, Inc.
0.04x--$142.42K

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.